NeuroPace Inc.

NPCE | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.67

+$0.13 (+0.89%)

Sep 22, 2026, 11:07 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.89%

(1D)

Rating

Updated: Aug 10, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $500.16M

1D Range

14.54 14.93

52W Range

9.22 19.60

Valuation (TTM)

PE -25.51

PB 41.72

EV/EBITDA -41.83

Valuation (NTM)

Forward PE N/A

Forward PEG 0.56

Price Target $20.25

Cash Flow

FCF Yield -2.3%

SBC Adj. FCF Yield -4.3%

SBC Impact -84.5%

Margins

Gross Margin 79.6%

Operating Margin -15.3%

FCF Margin -11.8%

Growth (CAGR)

Revenue 3Y | 5Y 21.6% | 15.8%

Dil EPS 3Y | 5Y 31.7% | 27.3%

FCF 3Y | 5Y 18.8% | 27.5%

Returns

ROA -19.7%

ROE -119.7%

ROIC -18.4%

Financial Health

Net Debt

$7.32M

Current Ratio 4.94

Interest Coverage -2.39

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at...

Sector Healthcare

Industry Medical - Devices

Employees 220

IPO Date Apr 21, 2021

Website www.neuropace.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$20.50

Upside

+39.74%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞